Genomics gives humanity extraordinary power: the ability to read, compare, select and potentially rewrite the biological information of living organisms.
Used wisely, this power can reduce suffering, diagnose disease, protect endangered species, improve food security and deepen our understanding of life. Used recklessly, it can harm people, destabilize ecosystems and create consequences that may be irreversible.
The Genomic Power Shift is written from a position of scientific curiosity and technological optimism, but also from a clear commitment to restraint, human dignity and long-term responsibility.
These are the principles that guide that position.
First, do no harm
We follow the spirit of the Hippocratic tradition: first, do no harm.
In medicine, genomics should serve the patient. It should be used to diagnose, treat, prevent and reduce suffering — not to frighten, exploit, overpromise or create unnecessary anxiety.
Genetic information can be powerful, but it can also be uncertain, incomplete or emotionally difficult. Any use of genomics in health should be guided by care, consent, evidence and humility.
Reject social Darwinism
We reject social Darwinism completely.
Genomics can describe biological variation. It must never be used to justify social hierarchy.
No human being is worth more or less because of ancestry, genetic background, disability, health, intelligence, appearance, fertility, physical strength or any other inherited trait. Human dignity is not conditional on biology.
The history of genetics includes eugenics, racial classification, forced sterilization and attempts to rank human beings by inherited characteristics. These ideas were scientifically abusive, politically dangerous and morally catastrophic.
A genomic future must not revive them in cleaner language.
Modify humans for health, not status
Human genetic modification should be limited to serious health reasons.
In principle, it may become possible to select or engineer embryos for traits such as height, intelligence, appearance, athletic ability or other socially desirable characteristics. We should not go down that road.
The use of embryo selection or human genetic engineering should be restricted to strong medical purposes: preventing severe disease, reducing serious suffering or addressing clearly defined health risks.
A society that begins designing children for preference, competition or status risks turning human life into a consumer product. That would not be progress.
Preserve the living world
We should be extremely cautious about spreading genetically modified organisms into nature.
This does not mean every use of genetic modification is wrong. It means that open release into ecosystems should require a clear and serious justification. Nature is not a contained laboratory. Once a modified organism spreads through an ecosystem, it may be impossible to recall.
There may be cases where intervention is morally justified: preventing mass extinction, controlling devastating disease, protecting food security or repairing ecological damage. But the default position should be restraint, humility and strong evidence.
Protect the biosphere as a shared inheritance
The biosphere is not raw material. It is the living foundation on which every human future depends.
Genomic technologies must be judged not only by whether they work, but by what they do to ecosystems, species, evolutionary processes and the long-term resilience of life on Earth.
The extinction of species, collapse of ecosystems or genetic disruption of wild populations cannot be treated as acceptable collateral damage. The living world is an inheritance we received, not a possession we are free to exhaust.
Respect Indigenous rights and biological sovereignty
Genomics must respect the rights of Indigenous peoples and local communities.
Land, species, seeds, animals, plants, ecological knowledge and biological samples are not neutral resources waiting to be extracted. Many are embedded in histories, cultures, territories and relationships that long predate modern biotechnology.
Research and commercial use involving Indigenous lands, biological resources or traditional knowledge should require genuine consent, fair benefit-sharing and respect for local governance. Genomics must not become another form of extraction.
Consent matters
Human genomic data is not ordinary data.
A genome can reveal information about a person, their relatives, their ancestry, their health risks and sometimes their future children. It can expose family secrets, identify biological relatives and create risks that extend beyond the individual who provided the sample.
For that reason, genomic data should be collected, stored, shared and commercialized only with meaningful consent, strong protection and clear limits. People should understand what is being done with their biological information, who may access it, and what the consequences may be.
Public leadership over biological free-for-all
The modification of human genomes or the shared biosphere should not become a free-for-all.
Decisions of this scale should not be left only to private companies, wealthy individuals, authoritarian states, competitive research groups or market incentives. The governance of human and environmental genetic modification must be public, international and accountable.
The development of artificial intelligence has shown what can happen when powerful technologies are released through competitive acceleration. Genomics is different in one crucial respect: changes to humans, species or ecosystems may be biological, heritable and irreversible.
The stakes are too high for an arms race.
Ban genetically modified bioweapons
The use of genomics to create, enhance or target biological weapons should be treated as one of the clearest red lines of the genomic era.
Biotechnology should be used to protect life, not to engineer disease, ecological damage or biological terror. The deliberate creation or modification of pathogens for hostile use should be internationally prohibited, aggressively monitored and treated as a threat to humanity as a whole.
This principle should be simple: no engineered bioweapons.
Share benefits fairly
The benefits of genomics should not belong only to the richest countries, companies or individuals.
Many populations have historically been excluded from genomic research, while others have been studied without receiving fair benefits in return. A responsible genomic future must include global fairness: broader representation, better access to medical advances, fair partnerships and respect for the people whose biological data makes discovery possible.
Genomics should not widen the gap between those who can afford biological advantage and those who cannot.
Use precaution without paralysis
Responsible restraint is not the same as fear.
Genomics can do enormous good. It can help children with rare diseases, improve cancer treatment, track epidemics, protect endangered species and make agriculture more resilient. A blanket rejection of biotechnology would be neither realistic nor moral.
But powerful tools require proportionate caution. The right approach is not panic, and it is not reckless acceleration. It is careful, transparent, evidence-based progress with strong ethical boundaries.
Think in centuries
Many technologies change a market, an industry or a generation. Genomics can change lineages, species and ecosystems.
That means the time horizon must be longer. Decisions about heritable human modification, gene drives, engineered organisms and biological systems should be made with future generations in mind.
The question is not only whether something can be done now. The question is whether people hundreds or thousands of years from now would recognize it as wise.
The commitment
The Genomic Power Shift is committed to a future where genomics serves life rather than diminishes it.
That means defending human equality, protecting the biosphere, respecting Indigenous rights, supporting responsible medicine, resisting genetic consumerism, opposing engineered bioweapons and insisting that the most consequential biological decisions are made with democratic legitimacy and international oversight.
The aim is not to stop the genomic future.
The aim is to make sure it remains human.